John Orr, MD
Dermatology · Pittsburgh, PANPI 1700442464
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,234 of the $6,708 with a category attached, or 63.1%. 17 manufacturers reported payments, led by Johnson & Johnson at 51.5% of the total. 2025 is the largest year on record at $4,571, more than ten times the $414 reported in 2023.
Across 231 payments — averaging $29.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Sanofi$745
- AbbVie$610
- Galderma Laboratories, L.p.$327
- Novartis$326
- Lilly USA, LLC$233
- plus $1K from 11 others
What the payments were for
- Consulting fees$2,20033%
- Food & beverage$4,23463%
- Education$2744%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 71 | $3,453 |
| Sanofi | 28 | $745 |
| AbbVie | 36 | $610 |
| Galderma Laboratories, L.p. | 24 | $327 |
| Novartis | 16 | $326 |
| Lilly USA, LLC | 15 | $233 |
| Regeneron Healthcare Solutions, Inc. | 6 | $185 |
| Dermavant Sciences, Inc. | 13 | $157 |
| Revance Therapeutics, Inc. | 2 | $155 |
| Incyte Corporation | 6 | $150 |
| Sun Pharmaceutical Industries Inc. | 2 | $131 |
| LEO Pharma Inc. | 1 | $113 |
| Arcutis Biotherapeutics, Inc. | 3 | $48 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| UCB, Inc. | 1 | $19 |
| Biofrontera Inc. | 1 | $18 |
| Organon | 5 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,708 in reported general payments places this provider in the 75th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 20 | $81,078 |
| Clobetasol Propionate | 154 | $5,637 |
| Triamcinolone Acetonide | 245 | $2,892 |
| Tacrolimus | 25 | $2,630 |
| Ketoconazole | 249 | $2,351 |
| Metronidazole | 44 | $2,130 |
| Clindamycin Phosphate | 50 | $1,840 |
| Calcipotriene | 11 | $1,323 |
| Doxycycline Hyclate | 113 | $1,230 |
| CiclopiroxCiclopirox Olamine | 108 | $965 |
| Hydrocortisone | 159 | $684 |
| Mupirocin | 69 | $367 |
| Prednisone | 96 | $348 |
| Gabapentin | 57 | $241 |
| ValacyclovirValacyclovir Hcl | 25 | $218 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Pittsburgh
- Neil NirenPittsburgh$574K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
- Joe TungPittsburgh$404K
- Charles MountPittsburgh$189K
- Timothy PattonPittsburgh$72K
- Daniel KaplanPittsburgh$46K
- Hassane ZarourPittsburgh$44K
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.